Vireo completed the acquisition of Hawthorne from Scotts Miracle-Gro, receiving $110 million in cash and net working capital plus inventory to support operations over the next two years. The deal was financed by issuing 213 million shares and 80 million warrants, deepening Vireo’s cultivation supply chain capabilities and strengthening its balance sheet for future growth initiatives.

Cresco Labs and Green Thumb secured conditional licenses under Phase II of the Texas Compassionate Use Program, granting them preliminary approval to cultivate and distribute medical cannabis in the state. Final approvals hinge on financial and regulatory reviews, and both companies must become operational within 24 months or risk permit revocation.

The Cannabist Company Holdings initiated Chapter 15 filings in the U.S. and creditor proceedings in Canada, citing $270 million in outstanding obligations. It has completed asset sales of $130 million in Virginia and $63.5 million in Ohio and Delaware, while pursuing further divestments of non-core state operations.